Contest Trader

Don't miss the chance to cash-in prizes totaling

$10.000
Register here for the Ultimate demo trading competition

Dow Jones Industrial Average changes components

Dow Jones Industrial Average changes components

The effect of the AAPL stock split reverberates in USA30

The blue-chip index makes its first significant component change since 2013

The week started with some changes for one of the most important American indices – USA30 (Dow Jones Industrial Average 30). The index representatives announced a shake-up, as they will switch out three stocks for the second time in a decade, and the third time in a millennium. The last time when a replacement took place was in 2013 when Alcoa, Bank of America, and Hewlett-Packard have been replaced by Goldman Sachs, Nike, and Visa.

The new companies that will be part of USA30 are Salesforce.com, Amgen, and Honeywell International. To make room for the new companies, others will have to leave the index. Those who will leave USA30 are Exxon Mobil, Pfizer, and Raytheon Technologies.

#Apple's decision to do a 4-for-1 stock split made the change possible. By this, the benchmark’s exposure to the information technology sector diminished from 27.6% to 20.3%. Salesforce.com’s inclusion will bring the technology within the #DJIA to 23.1%.

The changes will happen on August 31, before the opening bell.

From the specialists' point of view, the swap shows the changing picture of the market. Also, it "help(s) diversify the index by removing overlap between companies of similar scope and adding new types of businesses that better reflect the American economy," read the statement from Dow Jones.

Since March 23, USA30 has gained roughly 55%. It’s still 4% under its all-time high of 29,568.57 reached on February 12. Following the announcement, shares of Exxon, Pfizer, and Raytheon lost about 2%. Their replacements gained 4%.

Year to date, Salesforce.com share gained 28%, Amgen’s lost 2.3%, and Honeywell stocks are down 10%.

Sources: marketwatch.com, cnbc.com

Maklumat yang disediakan oleh za.capex.com bukan berbentuk tawaran atau permintaan untuk tujuan pembelian atau penjualan apa-apa produk kewangan yang disebutkan di sini atau melibatkan perundngan, atau nasihat mahupun cadangan berkenaan dengan kewangan produk tersebut.

Maklumat ini disediakan untuk edaran umum. Ia tidak mengambil kira objektif pelaburan tertentu, keadaan kewangan atau keperluan tertentu dari mana-mana penerima.

Anda harus bebas menilai setiap produk kewangan dan mempertimbangkan kesesuaian produk kewangan sedemikian, dengan mengambil kira objektif pelaburan tertentu anda, keadaan kewangan atau keperluan khusus, dan berunding dengan penasihat kewangan bebas, sebelum berurusan dalam produk kewangan yang disebutkan dalam dokumen ini.

Maklumat ini tidak boleh diterbitkan, diedar semula, diterbitkan semula atau diedarkan secara keseluruhan atau sebahagian kepada mana-mana individu lain tanpa kebenaran bertulis daripada Syarikat terlebih dahulu.

Prestasi lalu tidak sentiasa menggambarkan prestasi atau kemungkinan masa depan. Sebarang pandangan atau pendapat yang dikemukakan hanyalah pandangan penulis semata-mata dan tidak mewakili za.capex.com